J&J PALMAZ-SCHATZ CORONARY STENT PHYSICIAN TRAINING BEGINNING
This article was originally published in The Gray Sheet
Executive Summary
J&J PALMAZ-SCHATZ CORONARY STENT PHYSICIAN TRAINING BEGINNING following FDA approval of the device on Aug. 2. Shipments of the device, which is indicated for use in selected patients with coronary artery disease who are eligible for balloon angioplasty, are expected to begin after the training program goes into full swing.